Literature DB >> 6714054

Effect of antacids on predicted steady-state cimetidine concentrations.

W L Russell, L M Lopez, S A Normann, P L Doering, R T Guild.   

Abstract

The purpose of this study was to evaluate effects of antacids on predicted steady-state concentrations of cimetidine. Ten healthy volunteers received in random order one week apart, cimetidine and cimetidine and antacid suspension. Blood was obtained at specified times and analyzed for cimetidine. Bioavailability was assessed by comparison of peak concentration, time to peak concentration, area under the curve, and time spent over 0.5 micrograms/ml. Single-dose data were extrapolated to steady-state using computer simulation. Concurrent administration of antacid suspension reduced parameters of bioavailability approximately 30%. When steady-state conditions were simulated, concentrations of cimetidine greater than or equal to 0.5 micrograms/ml were maintained for the entire dosing interval in seven of 10 subjects. These data suggest that temporal separation of cimetidine and antacid suspension may be unnecessary.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6714054     DOI: 10.1007/bf01296210

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  10 in total

1.  High-pressure liquid chromatographic analysis of cimetidine, a histamine H2-receptor antagonist, in blood and urine.

Authors:  W C Randolph; V L Osborne; S S Walkenstein; A P Intoccia
Journal:  J Pharm Sci       Date:  1977-08       Impact factor: 3.534

2.  Bioavailability and pharmacokinetics of cimetidine.

Authors:  A Grahnén; C von Bahr; B Lindström; A Rosén
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

3.  Diminished absorption of cimetidine caused by antacids.

Authors:  G Bodemar; B Norlander; A Walan
Journal:  Lancet       Date:  1979-02-24       Impact factor: 79.321

4.  Effect of antacids on absorption of cimetidine.

Authors:  W L Burland; D W Darkin; M W Mills
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

5.  Antacids inhibit absorption of cimetidine.

Authors:  W M Steinberg; J H Lewis; D M Katz
Journal:  N Engl J Med       Date:  1982-08-12       Impact factor: 91.245

6.  Inhibition of gastric acid secretion by cimetidine in patients with duodenal ulcer.

Authors:  R M Henn; J I Isenberg; V Maxwell; R A Sturdevant
Journal:  N Engl J Med       Date:  1975-08-21       Impact factor: 91.245

7.  Impaired cimetidine absorption due to antacids and metoclopramide.

Authors:  R Gugler; M Brand; A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

8.  Cimetidine dynamics after single intravenous doses.

Authors:  S Pancorbo; M P Bubrick; T W Chin; K W Miller; G Onstad
Journal:  Clin Pharmacol Ther       Date:  1982-01       Impact factor: 6.875

9.  Computer-simulated conversion from intravenous to sustained-release oral theophylline.

Authors:  R P Iafrate; V P Gotz; J D Robinson; S M Lupkiewicz
Journal:  Drug Intell Clin Pharm       Date:  1982-01

10.  Cimetidine plasma concentration-response relationships.

Authors:  R Gugler; G Fuchs; M Dieckmann; A A Somogyi
Journal:  Clin Pharmacol Ther       Date:  1981-06       Impact factor: 6.875

  10 in total
  2 in total

Review 1.  Clinically significant drug interactions with antacids: an update.

Authors:  Ryuichi Ogawa; Hirotoshi Echizen
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

Review 2.  Effects of antacids on the clinical pharmacokinetics of drugs. An update.

Authors:  R Gugler; H Allgayer
Journal:  Clin Pharmacokinet       Date:  1990-03       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.